Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Gut-Lung Axis in COVID-19
Imane Allali, Youssef Bakri, Saaïd Amzazi, et al.
Interdisciplinary Perspectives on Infectious Diseases (2021) Vol. 2021, pp. 1-6
Open Access | Times Cited: 36

Showing 1-25 of 36 citing articles:

Short chain fatty acids: key regulators of the local and systemic immune response in inflammatory diseases and infections
Lisa-Marie Ney, Maximilian Wipplinger, Martha Grossmann, et al.
Open Biology (2023) Vol. 13, Iss. 3
Open Access | Times Cited: 105
Evidences and perspectives of the use of probiotics, prebiotics, synbiotics, and postbiotics as adjuvants for prevention and treatment of COVID-19: A bibliometric analysis and systematic review
Douglas Xavier-Santos, Marina Padilha, Giovanna Alexandre Fabiano, et al.
Trends in Food Science & Technology (2022) Vol. 120, pp. 174-192
Open Access | Times Cited: 101
Long COVID: a review and proposed visualization of the complexity of long COVID
Rubeshan Perumal, Letitia Shunmugam, Kogieleum Naidoo, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 63
Diagnostic, Prognostic, and Therapeutic Roles of Gut Microbiota in COVID-19: A Comprehensive Systematic Review
Yeganeh Farsi, Azin Tahvildari, Mahta Arbabi, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 62
Short-chain fatty acids improve inflamm-aging and acute lung injury in old mice
Christina B. Hildebrand, Rita Lichatz, Andreas Pich, et al.
AJP Lung Cellular and Molecular Physiology (2023) Vol. 324, Iss. 4, pp. L480-L492
Closed Access | Times Cited: 22
Biological mechanisms underpinning the development of long COVID
Rubeshan Perumal, Letitia Shunmugam, Kogieleum Naidoo, et al.
iScience (2023) Vol. 26, Iss. 6, pp. 106935-106935
Open Access | Times Cited: 21
The effect of synbiotic adjunct therapy on clinical and paraclinical outcomes in hospitalized COVID‐19 patients: A randomized placebo‐controlled trial
Mahsa Vaezi, Sahar Ravanshad, Mina Akbari Rad, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 2
Closed Access | Times Cited: 17
Coronavirus disease 2019 and the gut–lung axis
Dan Dan Zhou, Qiu Wang, Hanmin Liu
International Journal of Infectious Diseases (2021) Vol. 113, pp. 300-307
Open Access | Times Cited: 33
Weil’s Disease—Immunopathogenesis, Multiple Organ Failure, and Potential Role of Gut Microbiota
Pavlo Petakh, Vitaliia Isevych, Oleksandr Kamyshnyi, et al.
Biomolecules (2022) Vol. 12, Iss. 12, pp. 1830-1830
Open Access | Times Cited: 26
Association of Gut Microbiota with Inflammatory Bowel Disease and COVID-19 Severity: A Possible Outcome of the Altered Immune Response
Anju Kaushal, Rashed Noor
Current Microbiology (2022) Vol. 79, Iss. 6
Open Access | Times Cited: 21
Probiotic effects of Clostridium cellabutyricum against Pseudomonas aeruginosa infection in antibiotic-induced gut microbial dysbiosis mice model
Mengling Wang, Yuanjie Zhang, Hong Xiao, et al.
International Journal of Antimicrobial Agents (2025), pp. 107503-107503
Closed Access
The gut microbiome in post-COVID syndrome patients
Yali Zhai, Xiaokang Li, Jiahai Lu, et al.
The Innovation Medicine (2025), pp. 100123-100123
Closed Access
Microbiome dysbiosis in SARS-CoV-2 infection: implication for pathophysiology and management strategies of COVID-19
Shukur Wasman Smail, Niaz Albarzinji, Rebaz Hamza Salih, et al.
Frontiers in Cellular and Infection Microbiology (2025) Vol. 15
Open Access
Gastrointestinal microbiota: A predictor of COVID-19 severity?
Maria Adriana Neag, Damiana-Maria Vulturar, Diana Gherman, et al.
World Journal of Gastroenterology (2022) Vol. 28, Iss. 45, pp. 6328-6344
Open Access | Times Cited: 15
COVID-19, the Gut, and Nutritional Implications
Matthew G. Bell, Ravindra Ganesh, Sara L. Bonnes
Current Nutrition Reports (2023) Vol. 12, Iss. 2, pp. 263-269
Open Access | Times Cited: 9
A Pictorial Essay Describing the CT Imaging Features of COVID-19 Cases throughout the Pandemic with a Special Focus on Lung Manifestations and Extrapulmonary Vascular Abdominal Complications
Barbara Brogna, Elio Bignardi, A. Megliola, et al.
Biomedicines (2023) Vol. 11, Iss. 8, pp. 2113-2113
Open Access | Times Cited: 7
Crosstalk between gut microbiota and COVID-19 impacts pancreatic cancer progression
Chunye Zhang, Shuai Liu, Ming Yang
World Journal of Gastrointestinal Oncology (2022) Vol. 14, Iss. 8, pp. 1456-1468
Open Access | Times Cited: 12
Gut microbiota and synbiotic foods: Unveiling the relationship in COVID‐19 perspective
Noor Akram, Farhan Saeed, Muhammad Afzaal, et al.
Food Science & Nutrition (2023) Vol. 11, Iss. 3, pp. 1166-1177
Open Access | Times Cited: 6
Exploring the binding capacity of lactic acid bacteria derived bacteriocins against RBD of SARS-CoV-2 Omicron variant by molecular simulations
İsmail Erol, Seyfullah Kotil, Fatih Ortakcı, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 41, Iss. 20, pp. 10774-10784
Closed Access | Times Cited: 5
Interactions between the Gut Microbiome, Lung Conditions, and Coronary Heart Disease and How Probiotics Affect These
Trudy M. Wassenaar, Valentina A. Juncos, Kurt Zimmermann
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 18, pp. 9700-9700
Open Access | Times Cited: 11
COVID-19 Spotlights Connections between Disease and Multiple Lifestyle Factors
Elizabeth J. Enichen, Caitlyn Harvey, Barbara Demmig‐Adams
American Journal of Lifestyle Medicine (2022) Vol. 17, Iss. 2, pp. 231-257
Open Access | Times Cited: 7
Molecular and cellular mechanisms involved in tissue-specific metabolic modulation by SARS-CoV-2
Alef Aragão Carneiro dos Santos, Luiz Eduardo Rodrigues, Amanda Lins Alecrim-Zeza, et al.
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 7
Post-COVID-19 syndrome: When an acute infection causes a chronic illness
Olga Helena Hernández Ortiz, Andrés Felipe Naranjo Ramírez, Andrea Sierra Ramírez, et al.
Acta Colombiana de Cuidado Intensivo (2024) Vol. 24, Iss. 4, pp. 387-397
Closed Access | Times Cited: 1
Alteration of the Gut–Lung Axis After Severe COVID-19 Infection and Modulation Through Probiotics: A Randomized, Controlled Pilot Study
Angela Horvath, Hansjörg Habisch, Barbara Prietl, et al.
Nutrients (2024) Vol. 16, Iss. 22, pp. 3840-3840
Open Access | Times Cited: 1
Leptin in the Respiratory Tract: Is There a Role in SARS-CoV-2 Infection?
Andreina Bruno, Giuliana Ferrante, Serena Di Vincenzo, et al.
Frontiers in Physiology (2021) Vol. 12
Open Access | Times Cited: 8
Page 1 - Next Page

Scroll to top